History
  • No items yet
midpage
Heraeus Med. GMBH v. Esschem, Inc.
285 F. Supp. 3d 855
E.D. Pa.
2018
Read the full case

Background

  • Heraeus (German bone cement maker) alleged Biomet obtained its trade secrets and supplied them to Esschem to produce copolymers (R262, R263) used in Biomet’s competing bone cements launched in August 2005.
  • Heraeus investigated after the 2005 launch and found Esschem‑branded raw materials delivered to Biomet’s contract manufacturer; Heraeus sued Biomet in Germany on December 30, 2008 alleging misappropriation.
  • Heraeus filed a 28 U.S.C. § 1782 discovery application against Esschem on January 29, 2009 to obtain evidence for the German action; after Third Circuit reversal, Esschem produced documents in 2010–2011 which Heraeus repeatedly said supported its misappropriation theory.
  • Discovery under the § 1782 proceeding concluded August 19, 2011; Heraeus then waited until September 8, 2014 to sue Esschem in Pennsylvania state court (asserting PUTSA misappropriation, conspiracy, unjust enrichment, unfair competition, tortious interference, and conversion).
  • Esschem moved for summary judgment, arguing all claims are time barred; the court found Heraeus knew or reasonably should have known the factual basis for its claims by January 29, 2009 at the latest, and granted summary judgment for Esschem.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether Heraeus’s PUTSA (trade secret) claims are timely Heraeus contends it needed § 1782 discovery (and additional discovery) before it could bring suit; statute tolled until it obtained proof Esschem argues Heraeus knew or should have known by 2009 and therefore PUTSA’s 3‑year SOL expired Court: Claims accrued by Jan 29, 2009 at latest; PUTSA 3‑year SOL time bars trade secret claims filed in 2014
When the PUTSA limitations period began (discovery rule) Heraeus: limitations should wait until it obtained the discovery proving misappropriation Esschem: discovery rule doesn’t permit tolling until plaintiff has all proof; objective knowledge starts accrual Court: Pennsylvania’s narrow discovery rule requires due diligence; Heraeus had objectively reasonable notice by 2009, so accrual began then
Whether alleged ongoing sales create separate accruals (continuing wrong) Heraeus: each subsequent use/sale is a new wrong restarting the limitations period Esschem: PUTSA rejects continuing‑wrong separate accrual; ongoing sales are continuation of original misappropriation Court: PUTSA does not treat misappropriation as continuing tort; separate accrual rejected
Timeliness of related tort claims (unjust enrichment, unfair competition, interference, conversion) Heraeus: same factual basis; discovery needs differ Esschem: same accrual date applies; differing SOL lengths still expired before filing Court: Applying 4‑yr (unjust enrichment) and 2‑yr (others) statutes to Jan 29, 2009 accrual, all non‑misappropriation claims are also time barred

Key Cases Cited

  • Celotex Corp. v. Catrett, 477 U.S. 317 (summary judgment standard on movant burden)
  • Anderson v. Liberty Lobby, 477 U.S. 242 (standard for genuine issue of material fact)
  • Oshiver v. Levin, Fishbein, Sedran & Berman, 38 F.3d 1380 (application of discovery rule / diligence)
  • Blanyar v. Genova Prods., Inc., 861 F.3d 426 (discovery rule and accrual discussion)
  • Bimbo Bakeries USA, Inc. v. Botticella, 613 F.3d 102 (statute of limitations principles)
Read the full case

Case Details

Case Name: Heraeus Med. GMBH v. Esschem, Inc.
Court Name: District Court, E.D. Pennsylvania
Date Published: Jan 25, 2018
Citation: 285 F. Supp. 3d 855
Docket Number: CIVIL ACTION NO. 14–5169
Court Abbreviation: E.D. Pa.